BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9217244)

  • 1. Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapies.
    de Jong MD; Boucher CA; Cooper DA; Galasso GJ; Gazzard B; Lange JM; Montaner JS; Richman DD; Thomas HC
    Antiviral Res; 1997 Jul; 35(2):65-82. PubMed ID: 9217244
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus symposium on combined antiviral therapy. International Society for Antiviral Research and the National Institutes of Allergy and Infectious Diseases.
    de Jong MD; Boucher CA; Galasso GJ; Hirsch MS; Kern ER; Lange JM; Richman DD
    Antiviral Res; 1996 Jan; 29(1):5-29. PubMed ID: 8721539
    [No Abstract]   [Full Text] [Related]  

  • 3. Summary of the III International Consensus Symposium on Combined Antiviral Therapy.
    Cohen Stuart JW; Boucher CA; Cooper DA; Galasso GJ; Richman DD; Thomas HC; Whitley RJ
    Antiviral Res; 1998 May; 38(2):75-93. PubMed ID: 9707371
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus symposium on combined antiviral therapy. Lisbon, Portugal, July 25-27.
    Antiviral Res; 1996 Jan; 29(1):3-122. PubMed ID: 8801825
    [No Abstract]   [Full Text] [Related]  

  • 5. Current and future antiviral agents for chronic hepatitis B.
    Yuen MF; Lai CL
    J Antimicrob Chemother; 2003 Mar; 51(3):481-5. PubMed ID: 12615847
    [No Abstract]   [Full Text] [Related]  

  • 6. The implications of drug resistance for strategies of combination antiviral chemotherapy.
    Richman DD
    Antiviral Res; 1996 Jan; 29(1):31-3. PubMed ID: 8721540
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy for hepatitis B.
    Di Bisceglie AM
    Gut; 2002 Apr; 50(4):443-5. PubMed ID: 11889057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination Antiretroviral Therapy for HIV Infection. Proceedings of an international symposium. Berlin, Germany, March 25-26, 1995.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():v, S1-82. PubMed ID: 8595500
    [No Abstract]   [Full Text] [Related]  

  • 9. Future prospects for antiviral agents and new approaches.
    Galasso GJ
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():127-36. PubMed ID: 6208182
    [No Abstract]   [Full Text] [Related]  

  • 10. The faster the better?
    Carulli N
    Intern Emerg Med; 2006; 1(2):91-3. PubMed ID: 17111779
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antiviral treatment of chronic hepatitis B: monotherapy or combination therapy].
    Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):401-3. PubMed ID: 18578985
    [No Abstract]   [Full Text] [Related]  

  • 12. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

  • 13. New anti-HIV-1 therapies and combinations: current data and prospects.
    Eron JJ; Hirsch MS
    AIDS; 1990; 4 Suppl 1():S193-200. PubMed ID: 2152567
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined use of antiviral preparations].
    Ershov FI; Chizhov NP
    Vopr Virusol; 1984; 29(6):644-56. PubMed ID: 6084895
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis C: current therapy].
    Moradpour D; Müllhaupt B
    Rev Med Suisse; 2015 Apr; 11(471):902-6. PubMed ID: 26072595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Status of therapy of HIV infections. A long way to standardized procedure].
    Gürtler L
    Fortschr Med; 1993 Oct; 111(30):25-6. PubMed ID: 8258426
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C - what does the future hold?
    Bain VG
    Can J Gastroenterol; 2000; 14(7):571-2. PubMed ID: 10978941
    [No Abstract]   [Full Text] [Related]  

  • 18. Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections.
    de Jong MD; Boucher CA; Danner SA; Gazzard B; Griffiths PD; Katlama C; Lange JM; Richman DD; Vella S
    Antiviral Res; 1998 Jan; 37(1):1-16. PubMed ID: 9497068
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination].
    Niederau C
    MMW Fortschr Med; 2008 Mar; 150(13):26. PubMed ID: 18522352
    [No Abstract]   [Full Text] [Related]  

  • 20. New protease drug shows early promise.
    Levin J
    BETA; 1995 Sep; ():27, 33. PubMed ID: 11362887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.